This thread has been destroyed by the abuse of sequestor and dil

If you have any sense you will use the squelch facility, and get rid of both these morons, until MAM finally get their finger out and ban them





























This thread has been destroyed by the abuse of sequestor and dil

If you have any sense you will use the squelch facility, and get rid of both these morons, until MAM finally get their finger out and ban them






























This thread has been destroyed by the abuse of sequestor and dil

If you have any sense you will use the squelch facility, and get rid of both these morons, until MAM finally get their finger out and ban them


















This thread has been destroyed by the abuse of sequestor and dil

If you have any sense you will use the squelch facility, and get rid of both these morons, until MAM finally get their finger out and ban them

.

Why the rise no new news?
lindos

heading towards 3p.. looking good

Any body know whats going on at minster!!

Lindos

NEWS

Minster Pharmaceuticals, a drug development company specialising in neurological and psychiatric disorders, announced today that it has recruited the first patients in a multi-national Phase II clinical trial of tonabersat, the Company's lead compound, in the prevention of migraine.
The first patients have been recruited to the Danish Headache Centre at Glostrup Hospital, Copenhagen which will be followed by patient recruitment at centres in the UK, Hungary and South Africa.

- -

It is anticipated that around 130 patients in total will be recruited to the trial, which will involve patients taking either tonabersat or placebo on a once-daily basis for three months. The primary endpoint of the trial will be the reduction in the number of days that patients suffer a migraine. The timing of the results of the trial, which will in part be influenced by the speed of patient recruitment, is expected to be during the first quarter of 2007.

Tonabersat is in an exciting new class of drugs called gap junction blockers, which are the subject of significant interest from clinicians and pharmaceutical researchers for their potential in the prevention of migraine as an alternative to current acute treatments. Minster Pharmaceuticals acquired rights to tonabersat in early 2001 from GlaxoSmithKline, which conducted extensive toxicological and clinical studies on the compound, establishing its safety profile and providing promising evidence of activity in the treatment of migraine.

Good news as well as Nomura. Small sellers and the price is down. Good time to buy more stock!

Has anyone heard any futher updates as to how the testing is going ? Surely if these go well the price ought to fly....big if tho i know, but definitely one to keep an eye on i've been told. Any comments welcomed

what's gone on today, seeing as price has dropped ?

I cannot obviously remember, but were the current shareholders ever asked to vote on this new placing of further shares ? Surely we should have been....